Introduction
The term "juvenile Paget's disease" was first used to describe an unusual bone disease occurring in an 11-year-old boy (Choremis et al., 1958) . Several further examples of what appears to be the same or a similar disorder have been reported and variously named "fragle bones and macrocranium" (Bakwin and Elder, 1956) , "hyperostosis corticalis deformans juvenilis" (Swoboda, 1958) , "chronic idiopathic hyperphosphatasia" (Caffey, 1961) , "chronic progressive osteopathy with hyperphosphatasia" (Marshall and Moncrieff, 1962) , "osteochalasia desmalis familiaris" (Facon et al., 1964) , "familial osteoectasia" (Stimmerman, 1966) , "hereditary hyperphosphatasia (Thompson et at., 1969) , and "congenital hyperphosphatasia" (Eyring and Eisenberg, 1968) .
The disease is apparently transmitted as an autosomal recessive trait (Thompson et al., 1969) and characterized by deformity in early life, fragile bones, and raised serum alkaline phosphatase and acid phosphatase levels. Urine hydroxyproline excretion is increased, and studies using tetracycline lablling of bone and stable strontium measurements have confirmed the high bone turnover rate (Thompson et al., 1969; Eyring and Eisenberg, 1968) . Although usually a generalized disease, involvement of a single bone may occur (Thompson et al., 1969) .
The clinical features and results of laboratory studies in a further case of this rare disorder are outlined in this report. In addition, the acute response to treatment with synthetic human calcitonin is described. It is expected that the raised bone turnover will eventually fall to normal as occurs in adult Paget's disease (Woodhouse et al., 1971 
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There was no family history of bone disease, and biochemical screening of the parents was normal.
The illness was first noted at the age of I years, after a fall and fractum of the right femur. Since then seven further fractures have occurred, all in the long bones (see Table) . All fractures healed normally. There has been no chronic bone pain. The akaline phosphatase levels had always been very high, and were still rising (Fig. 2) , and the bone deformities were progressive.
The home diet was normal, containing about 620 IU of vitamin D, and 1,200 mg of calcium a day.
At eamnation the height was 119 cm (97th percentile), and the weight was 20 kg (75th percentile). Bone deformity was apparet in the left humerus and both tibiae. There was asymmetrical deformity of the forehead. There was no bone tenderness or bruit, the overlying skin was not unduly warm, and the sclerae were white. The blood pressure was 120/80 mm Hg. Muscularity was normal. Other systems were clinically normal.
The patient was studied under metabolic balance conditions using chromium sesquioxide as a faecal marker (Whitby and Lang, 1960) . Seven days equilibration was followed by a nine-day control balance, and 15 days' balance on synthetic human calcitonin (CibaGeigy 47 175-Ba) (Sieber et al., 1970) 0-5 mg intramuscularly twice daily. He was then discharged home on the same treatment.
Standard Autoanalyser techniques were used for the serum biochemistry and urine uric acid, phosphate, and faecal phosphate (Wootton, 1964) . Urine and faecal calciums were measured by flame spectrophotometry (Maclntyre, 1960) , urine hydroxyproline by the method of Kivirkko et al. (1967) , and faecal chromium by modification (Fisher et al., 1972) of the method of Hartford (1953) .
Investigations were: haemoglobin 13-1 g/100 ml, W3B.C 5,900/ mm', E.S.R. 4 mm in one hour, blood urea 24 mg/100 ml, serum uric acid 4-8 mg/100 ml, albumin 4-2 g/100 ml, 5-nucleotidase 1 IU, urine uric acid 0-38 and 0-17 g/24 hr (normal for adults < 04 g). (Dunnigan and Gardner, 1965) , most of which was of bone origin (Dr. D. Moss). The total acid phosphatase was 6-3 and 7-2 K.A.U. (normal adult range 1-5-3-5).
X-ray pictures (Dr. F. H. Doyle) showed widespread abnormalities in bone structure, the most striking being in the diaphyses of the long bones of the limbs (Fig. 3) The serum phosphate (normal for age 2-0-3-2 mEq/l.) (Thalassinos et al., 1970 ) also fell slightly from 2-9, 3-4, and 3-7 to 2-4, 2-9, and 2-4 mEq/l. The urine hydroxyproline (normal for age <60 mg/ 24 hr) (Pappas, et al., 1971 ) was initially extremely high. It fell immediately (Fig. 4) apart from a small rise during the first pool on calcitonin from a mean control output of 484 mg/day to 595 mg/day. Faecal phosphate fell from the control output of 289 mg/day to 167 mg/ day in the last three pools on treatment (P < 0-05). Thus phosphate balance became more positive, rising fromn + 394 mg/day to + 555 mg/day. Nitrogen balance showed no change. Faecal fat averaged 2 5 g/day.
Discussion
Human calcitonin has produced a pronounced reduction in bone turnover in a patient with juvenile Paget's disease, evidenced by an immediate and sustained fall in urine hydroxyproline excretion. At the same time intestinal calcium absorption increased. This was probably due to a rise in circulating parathyroid hormone (Woodhouse et al., 1971) or 1,25 dihydroxycholecalciferol (Galante et al., 1972 ) levels, or both. These changes also occur in adult patients with Paget's disease, in whom bone turnover returns to normal during long-term treatment with human synthetic calcitonin (Woodhouse et al., 1971) . A similar response in the present patient may be expected. The aim of such treatment is to prevent further bone deformity and to reduce the excessive bone fragility. As normal lamellar bone is formed (Woodhouse et al., 1971; Bordier et al., 1972 ) the latter is possible and could lead to a reduction in deformity. Whether or not the bone fragility can be reduced depends on its cause. If as previously suggested the disease process is a variant of fragilitas ossium (Eyring and Eisenberg, 1968 ) then a favourable result is unlikely. If, however, the fragility is due simply to the formation of structurally abnormal bone as in adult Paget's disease (Schmorl, 1932; Bordier et al., 1972) successful treatment should prevent further fractures.
The histological findings in this case were similar to the other children previously reported (Eyring and Eisenberg, 1968; Thompson et al., 1969) and confirm the increased bone turnover; active osteoclasts and active osteoblasts were greatly increased in number. The changes in the present patient were indistinguishable from those found in active adult Paget's disease (Schmorl, 1932) . It is interesting to note that a similar patient with severe radiological changes had a normal serum alkaline phosphatase level, although osteoclasts and osteoblasts were abundant in the bone biopsy specimen (Bakwin and Elger, 1956 ). Loss of bone mass assessed radiologically has sometimes been reported but this was not observed in the present patient. Reduced bone mass would result from a relative increase in bone resorption over bone formation, a situation likely to be made worse or initiated by the gross restriction in physical activity that is frequently seen, and also by the occasional reported use of steroid medication (Eyring and Eisenberg, 1968) .
There are many striking similarities between adult Paget's disease and the high turnover bone disease described in children; serum alkaline and serum acid phosphatase levels are raised, urine hydroxyproline excretion is increased, and a mosaic pattem is present in the bone biopsy samples. Because of this, and to simplify matters, we used the eponym "Paget's" disease to describe the present patient, although we are fully aware that there is no proof linking the two diseases processes. 
Addendum
After three months' treatment a further reduction in bone turnover occurred. Serum alkaline phosphatase fell from 187 to 95 K.A.U., and urine hydroxyproline fell from 687 to 327 mg a day. In spite of several hard falls no further fractures occurred. Occasional mild nausea was the only reported side effect of the injections.
